Drug & intervention
carbidopa 61.25 MG / levodopa 245 MG [Rytary]
RxCUI 1599259
What this record represents
SBDC · RxNormThis is an RxNorm SBDC drug concept. Its name, formulation details and source identifiers are preserved to distinguish it from other drug records.
What this record does not establish: current marketing availability, therapeutic equivalence, safety, or official approval status. Check an up-to-date product label or a pharmacist for product-specific questions.
Related drug records
RxNorm name matchesThese are other published drug concepts with matching brand or formulation names. They are not necessarily equivalent medicines.
RytaryBN · CureCurrent ID 58991
carbidopa 23.75 MG / levodopa 95 MG [Rytary]SBDC · CureCurrent ID 59002
carbidopa 36.25 MG / levodopa 145 MG [Rytary]SBDC · CureCurrent ID 58992
carbidopa 48.75 MG / levodopa 195 MG [Rytary]SBDC · CureCurrent ID 58996
carbidopa / levodopa Extended Release Oral Capsule [Rytary]SBDF · CureCurrent ID 58993
8 HR carbidopa 23.75 MG / levodopa 95 MG Extended Release Oral Capsule [Rytary]SBD · CureCurrent ID 59100
8 HR carbidopa 36.25 MG / levodopa 145 MG Extended Release Oral Capsule [Rytary]SBD · CureCurrent ID 59102
8 HR carbidopa 48.75 MG / levodopa 195 MG Extended Release Oral Capsule [Rytary]SBD · CureCurrent ID 59109
8 HR carbidopa 61.25 MG / levodopa 245 MG Extended Release Oral Capsule [Rytary]SBD · CureCurrent ID 59111
Advertisement
Active ingredients and chemical structures
RxNorm ingredient relationships. Structures are retrieved by PubChem compound identifier when available. An ingredient can have both a base and a precise salt concept.
Conditions being studied
Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.